| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 01/24/2012 | US8101650 Method for treating a immunology-related disease |
| 01/24/2012 | US8101640 Antibacterial agents |
| 01/24/2012 | CA2528010C 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| 01/24/2012 | CA2511582C 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
| 01/19/2012 | WO2012009372A2 Triazolium carbene catalysts and processes for asymmetric carbon-carbon bond formation |
| 01/19/2012 | WO2012008435A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof |
| 01/19/2012 | WO2012007409A1 N-substituted pyrrolidines |
| 01/19/2012 | US20120016135 Furanose derivatives |
| 01/19/2012 | US20120016118 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
| 01/19/2012 | US20120016082 Conjugation reactions |
| 01/19/2012 | US20120015943 Substituted hydroxamic acids and uses thereof |
| 01/19/2012 | US20120015942 Substituted hydroxamic acids and uses thereof |
| 01/19/2012 | US20120015928 Amido Compounds And Their Use As Pharmaceuticals |
| 01/19/2012 | US20120015911 Method and compositions for treating amyloid-related diseases |
| 01/19/2012 | US20120014907 Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
| 01/18/2012 | EP2407453A1 PGD2 receptor antagonist |
| 01/18/2012 | EP2407452A1 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| 01/18/2012 | EP2407451A1 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 01/18/2012 | EP1642894B1 Quaternary ammonium salt, electrolyte, and electrochemical device |
| 01/18/2012 | CN1950351B 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
| 01/18/2012 | CN102321082A Naphthyridinone carboxylic acid compound and preparation method thereof |
| 01/18/2012 | CN102321008A Method for preparing N-phenyl succinimide |
| 01/18/2012 | CN102321007A Oxiracetam compound and preparation method as well as medicine composition thereof |
| 01/18/2012 | CN102321006A Di-proline amide compound containing chiral indane framework and application thereof |
| 01/18/2012 | CN102320920A Method for removing benzyl protecting group of hydroxyl group |
| 01/18/2012 | CN102319241A Application of compound in preparing anti-mammary cancer medicament aiming at CCL (CC chemokine ligand) 18 target |
| 01/18/2012 | CN101168523B Method for overturning syn-form 4-alkyl-N-tert-butoxycarbonyl pyroglutamic acid ester to anti-form product |
| 01/18/2012 | CN101107226B Phenoxyacetic acid derivatives useful for treating respiratory diseases |
| 01/18/2012 | CN101080415B Organometallic compounds and processes for preparation thereof |
| 01/17/2012 | US8097759 Inflammatory cytokine release inhibitor |
| 01/17/2012 | US8097721 High stability polyionic liquid salts |
| 01/17/2012 | US8097623 1-Aryl-or heteroaryl-3-aryl-or heteroarylindole-2-carboxylic acids or esters: e.g., 5-(4-tert-Butylphenyl)-1,3-bis(4-isopropoxyphenyl)-indole-2-carboxylic acid; inhibition of the activity of microsomal prostaglandin E synthase-1, leukotriene C4 and/or 5-lipoxygenase-activating protein; analgesics |
| 01/17/2012 | US8097611 Sulfonyl-derivatives as novel or histone deacetylase |
| 01/17/2012 | CA2559611C Pyrrolidine compounds |
| 01/17/2012 | CA2537587C Superhigh purity ionic liquid |
| 01/17/2012 | CA2494846C Arylamides |
| 01/17/2012 | CA2440577C Low molecular weight branched alkenyl succinic acid derivatives prepared from low molecular weight polyisobutene and unsaturated acidic reagents |
| 01/12/2012 | WO2012006205A1 Crystalline form of a 3-phenoxymethylpyrrolidine compound |
| 01/12/2012 | WO2012006202A1 Rho kinase inhibitors |
| 01/12/2012 | WO2012005200A1 Method for producing optically active 1,2-bis(dialkylphosphino)benzene derivative |
| 01/12/2012 | WO2012004326A1 Pesticidal pyrroline derivatives |
| 01/12/2012 | WO2012004210A1 Process and intermediates for preparation of an active ingredient |
| 01/12/2012 | US20120010425 Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof |
| 01/12/2012 | US20120010405 Optically active 3-amino-2,5-dioxopyrrolidine-3-carboxylate, process for production of the compound, and use of the compound |
| 01/12/2012 | US20120010265 Crystalline form of a 3-phenoxymethylpyrrolidine compound |
| 01/12/2012 | US20120010264 Novel medicament for treating cognitive impairment |
| 01/12/2012 | US20120010235 N-substituted pyrrolidines |
| 01/12/2012 | CA2803090A1 Crystalline form of a 3-phenoxymethylpyrrolidine compound |
| 01/11/2012 | EP2404911A1 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives |
| 01/11/2012 | EP2404903A1 Method of synthesizing [18f]sfb using microsynthesis technique |
| 01/11/2012 | EP2404902A1 Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism |
| 01/11/2012 | EP2404901A1 1,2-Disubstituted 4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |
| 01/11/2012 | EP2404899A1 Contrast medium for thrombus detection |
| 01/11/2012 | EP2404890A1 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 01/11/2012 | EP2403829A1 Cross-linking agents |
| 01/11/2012 | EP2170916B1 Furanose derivatives for the preparation of atorvastatin |
| 01/11/2012 | EP1809597B1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 01/11/2012 | CN102317260A Method for preparing N-substituted maleimides |
| 01/11/2012 | CN102317259A Fungicidal N-(phenylcycloalkyl)carboxamide, N-(benzylcycloalkyl)carboxamide and thiocarboxamide derivatives |
| 01/11/2012 | CN102317257A Process for the preparation of asymmetrical bis(thiosemicarbazones) |
| 01/11/2012 | CN102311981A Method for preparing and purifying prodigiosin |
| 01/11/2012 | CN102311377A Refining method capable of obtaining atorvastatin calcium in form of crystal |
| 01/11/2012 | CN102311376A Preparation process of atorvastatin calcium |
| 01/11/2012 | CN102311303A Organic EL device |
| 01/11/2012 | CN102070505B Atorvastatin calcium compounds and novel preparation method thereof |
| 01/11/2012 | CN102050774B Oxiracetam compound and new method thereof |
| 01/11/2012 | CN101774958B I-type crystal of N-n-propyl-3-(4-methylphenyl)-4-(4-mesylphenyl)-2,5-dihydropyrrole-2-ketone and manufacturing method thereof |
| 01/11/2012 | CN101466671B Novel microbiocides |
| 01/11/2012 | CN101346351B Alkoxyalkyl spirocyclic tetramic acids and tetronic acids |
| 01/10/2012 | US8093386 Thioaryl substituted inhibitors of zinc proteases and their use |
| 01/10/2012 | US8093274 Inhibitors of protein prenyltransferases |
| 01/10/2012 | CA2496756C Pyrrolidone derivatives as maob inhibitors |
| 01/05/2012 | WO2012002913A1 Process of forming a cyclic imide |
| 01/05/2012 | WO2012002527A1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR |
| 01/05/2012 | WO2011094545A3 Compositions and methods for enhancing proteasome activity |
| 01/05/2012 | US20120004413 Isotopically labeled chemically stable reagents and process for the synthesis thereof |
| 01/05/2012 | US20120004220 Selective androgen receptor modulators (sarms) and uses thereof |
| 01/05/2012 | US20120004157 Hydroxyproline compositions and uses thereof |
| 01/05/2012 | US20120000118 Low-molecular weight polyisobutyl-substituted amines as dispersant boosters |
| 01/05/2012 | CA2804225A1 Heterocyclic compound and p27kip1 degradation inhibitor |
| 01/04/2012 | EP2402351A1 Pyrromethene-boron complex compounds and organic electro- luminescent elements using same |
| 01/04/2012 | EP2402329A1 Analgetic phenylsulphonamides |
| 01/04/2012 | EP2402313A1 Process for producing pyrrole compound |
| 01/04/2012 | EP2402300A1 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 01/04/2012 | EP2401278A1 An improved process for the preparation of carbapenem antibiotic |
| 01/04/2012 | EP2401256A1 Compounds as bradykinin b1 antagonists |
| 01/04/2012 | EP2401253A2 A process for the preparation of etoricoxib |
| 01/04/2012 | CN102307889A Sulfurizing reagents and their use for oligonucleotides synthesis |
| 01/04/2012 | CN102307856A N-substituted pyrrolidonium ionic liquids with expanded linker |
| 01/04/2012 | CN102307855A N-substituted pyrrolidonium ionic liquids |
| 01/04/2012 | CN102307854A Mixtures of itaconic acid or itaconic acid derivatives and primary amines for producing 1,3- and 1,4-alkyl methyl pyrrolidones |
| 01/04/2012 | CN102307853A Pyrrolidine derivatives as NK3 receptor antagonists |
| 01/04/2012 | CN102307852A Cyclic amine compounds |
| 01/04/2012 | CN102304110A Hydroxamates as therapeutic agents |
| 01/04/2012 | CN102304075A Inhibitors of viral replication |
| 01/04/2012 | CN102304007A Asymmetric catalytic hydrogenation reaction method of intra-annular N-alkylimine |
| 01/04/2012 | CN101624363B Processing method of bile by ultrasonic wave |
| 01/04/2012 | CN101492421B Method for preparing trifluoro acetyl substituted ring amine and its derivative |
| 01/04/2012 | CN101372475B Aromatic heterocyclic substituted acardite derivative and use thereof |
| 01/03/2012 | US8088932 Pentaaryldiamine-containing bismaleimide compound and method of producing the compound |